PMNNasdaqPharmaceutical PreparationsFiscal year ends December 31
ProMIS Neurosciences Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.23+0.08 (+0.98%)
Close on Oct 19, 2026
- Market cap
- $75.24M
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about ProMIS Neurosciences from other investors
No posts about PMN yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.